Novartis AG (NVS) stock saw a modest uptick, ending the day at $105.48 which represents a slight increase of $0.76 or 0.73% from the prior close of $104.72. The stock opened at $104.47 and touched a ...

Chicago Partners Investment Group LLC bought a new stake in shares of Novartis AG (NYSE:NVS – Free Report) during the 4th ...

CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if ...

Incyte Corporation INCY is scheduled to report fourth-quarter and full-year 2024 results on Feb. 10, before the opening bell.

The Delhi High Court on February 3 passed an interim injunction restraining a pharmaceutical company from using the trademark ...

A Weibo post from the company confirmed that the Realme GT 7 Pro Racing Edition will launch in China in February this year. The exact launch date has yet to be announced. No other details about the ...

The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...

The partial failure of its NVS-02 navigation satellite on Sunday was the latest in a series of setbacks suffered by the ...